IHM
MRNS

Iguana Healthcare Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Iguana Healthcare Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$382K Hold
25,000
– – 0.25% 61
2017
Q4 		$816K Sell
25,000
-18,750
-43% -$505K 0.53% 53
2017
Q3 		$1.03M Buy
+43,750
New +$490K 0.56% 53
2015
Q4 		– Sell
-18,750
Closed -$626K – 85
2015
Q3 		$626K Buy
+18,750
New +$1.06M 0.25% 68

Other funds holding MRNS

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Iguana Healthcare Management's MRNS Position: Q1 2018 in Review

Iguana Healthcare Management held its Marinus Pharmaceuticals, Inc (MRNS) position steady in Q1 2018 at 25,000 shares worth $382K. The position accounts for 0.25% of the portfolio, ranked #61.

Iguana Healthcare Management first reported a position in MRNS in Q3 2015 and has held it in 4 quarters since. The position peaked at $1.03M in Q3 2017. 60 funds tracked by Wall St. Rank hold MRNS as of Q1 2018.

  • Iguana Healthcare Management held 25,000 shares of Marinus Pharmaceuticals, Inc worth $382K as of Q1 2018.
  • Iguana Healthcare Management left its Marinus Pharmaceuticals, Inc share count unchanged in Q1 2018.
  • Marinus Pharmaceuticals, Inc made up 0.25% of Iguana Healthcare Management's portfolio in Q1 2018, its #61 holding.
  • Iguana Healthcare Management first reported a position in Marinus Pharmaceuticals, Inc in Q3 2015 and has held it in 4 quarters since.
  • Iguana Healthcare Management's Marinus Pharmaceuticals, Inc position peaked at $1.03M in Q3 2017.
  • 60 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.